Our results showed that repeated stimulation of anti-BCMA-CAR3 T cells with NCI-H929 (BCMAhigh) cells did not lose anti-tumor activity (Fig. 6B), indicating their excellent persistence. The gene discussed is TNFRSF17; the disease is neoplasm.